InvestorsHub Logo
Sticky
SkeBallLarry
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Tree Grandfathered
04/03/25 1:00 PM
profile icon
Tree Grandfathered
04/02/25 10:08 AM
profile icon
SkeBallLarry PremiumMember
04/01/25 9:34 AM
profile icon
Tree Grandfathered
04/01/25 7:57 AM
profile icon
Tree Grandfathered
03/31/25 11:27 AM
profile icon
SkeBallLarry PremiumMember
03/31/25 9:21 AM
profile icon
SkeBallLarry PremiumMember
03/31/25 8:17 AM
profile icon
SkeBallLarry PremiumMember
03/31/25 7:48 AM
profile icon
Tree Grandfathered
03/31/25 7:25 AM
profile icon
SkeBallLarry PremiumMember
03/29/25 6:18 AM
profile icon
Tree Grandfathered
03/28/25 11:08 AM
profile icon
SkeBallLarry PremiumMember
03/28/25 9:33 AM
profile icon
Tree Grandfathered
03/28/25 8:40 AM
profile icon
Tree Grandfathered
03/28/25 8:40 AM
profile icon
SkeBallLarry PremiumMember
03/27/25 11:31 AM
profile icon
Tree Grandfathered
03/27/25 8:26 AM
profile icon
Tree Grandfathered
03/26/25 7:53 AM
profile icon
Tree Grandfathered
03/25/25 10:16 AM
profile icon
SkeBallLarry PremiumMember
03/25/25 9:26 AM

Ihubber's FUN House (FUNHouse) RSS Feed

Followers
197
Posters
426
Posts (Today)
2
Posts (Total)
321130
Created
04/22/03
Type
Free
Moderator Tree
Assistants SkeBallLarry Seminole Red wow_happens28 pos_stock_hoarder
  Welcome to the FUN House.    Post most anything that you like except for porn and polics please! 
  A very big tip of the hat to ONEBGG.  RIP, Gary.  You are missed.
   
         " Very Good Pink Panther Song "    
 
 
  " A Funny Panther Video "   
   
 

 


       






 

 

Board Info
Posts Today
2
Posts (Total)
321130
Posters
426
Moderator
Assistants
New Post
Play Episode
5min
Proactive - Interviews for investors
Actinogen targets $20B Alzheimer’s market with Xanamem
Actinogen Medical Ltd Managing Director and CEO Dr Stephen Gourlay talked with Proactive at the AIM's Small and Midcap conference about the company’s lead asset, Xanamem, and its development in Alzheimer’s disease and depression. Dr Gourlay explained that Xanamem is an oral, once-a-day drug designed to modulate cortisol levels in the brain without interfering with the body’s essential stress response. “We’ve also shown some positive data, you know, phase two and depression as well, which is very exciting because that validates its mechanism,” he said. He outlined the commercial opportunity in both Alzheimer’s and depression. While depression is more prevalent, the Alzheimer's market offers larger potential revenue. He noted that current treatments either have side effects or provide only temporary cognitive improvement, whereas Xanamem could modify the disease course with a better safety profile. Dr Gourlay discussed Actinogen’s recent momentum, including positive results in a depression trial, a number of peer-reviewed publications, and the upcoming interim analysis from its Alzheimer’s trial in Australia and the US. He said, “The upside from a positive Alzheimer’s trial is completely massive… a multi-billion dollar asset.” The company is currently trading below the total investment into drug development, which Dr Gourlay described as a compelling investment case. #Actinogen #Xanamem #AlzheimersResearch #DepressionTreatment #BiotechStocks #ClinicalTrials #Neuroscience #PharmaInnovation #ASX #ProactiveInvestors
Proactive - Interviews for investors
Qualitas funds soar as banks step back
Qualitas Ltd Group Managing Director Andrew Schwartz talked with Proactive at the AIM's Small and Midcap conference about the company's differentiated position in Australia's real estate investment management landscape. Andrew Schwartz explained that Qualitas operates at scale, supported by large institutional capital. “Some of those investors literally commit amounts of 1.7 billion and above to Qualitas,” he said, noting the firm can fund projects with hundreds of millions—territory once dominated by traditional banks. Schwartz highlighted the company’s deep property expertise, developed over decades, as a key driver of performance. He said, “We are deep sector, deep dive property people,” which allows them to manage funds based not just on lending metrics but also on underlying property fundamentals. The conversation also addressed Qualitas’ notable growth in funds management revenue since its 2021 IPO. Schwartz attributed this to structural shifts in the Australian finance market, where banks still represent 77% of a AU$477 billion sector—but their share is shrinking. “We’ve really got the benefit of filling a void in the market that the bank market just can’t fill,” he said. Roughly 80% of Qualitas' activities are in the housing sector, financing large-scale residential projects rather than retail home loans. Schwartz said the persistent supply shortage, despite rising interest rates, underpins property values and creates strong demand for capital. #Qualitas #RealEstateInvestment #InstitutionalCapital #AustralianHousing #PropertyFinance #AndrewSchwartz #HousingShortage #ASX #FundsManagement #ProactiveInvestors
Proactive - Interviews for investors
Lithium ION Energy secures joint venture with SureFQ to advance Urgakh Naran Lithium project
Lithium ION Energy Limited CEO Ali Haji joined Steve Darling from Proactive to announce a binding Joint Venture Agreement with SureFQ for the advancement of the Urgakh Naran lithium project in Mongolia. Under the agreement, ION will retain a 20% free carried interest through to commercial production, ensuring long-term participation in the project's success without additional financial commitments. SureFQ, a firm specializing in sustainable energy solutions and lithium resource development, will leverage its industry expertise and advanced extraction technologies to accelerate the project’s progress. As a strategic investor, SureFQ focuses on developing high-potential assets that support the global energy transition. Haji told Proactive SureFQ will provide $5.5 million in cash considerations to ION over 4.5 years. The company has committed to $8 million in development expenditures for Urgakh Naran over four years. ION Energy will maintain a 2.5% Net Smelter Return (NSR) royalty in perpetuity, ensuring a steady revenue stream from future production. Haji emphasized that ION Energy is a proven Direct Lithium Extraction (DLE) operator, focused on deploying modular extraction capacity to optimize efficiency. This partnership positions Urgakh Naran as a key lithium asset in Mongolia, furthering ION’s role in the global battery metals supply chain. #proactiveinvestors #lithiumionenergylimited #tsxv #ion #urgakhnaran #mongolia #lithium #IonEnergy #AliHaji #UrgakhNaran #SureFQ #MongoliaMining #LithiumExtraction #DLETechnology #BatteryMetals #EVSupplyChain #CriticalMinerals #MiningInvestment #ProactiveInvestors #JuniorMining
Proactive - Interviews for investors
Light Science Technologies CEO on Injecta Fire Barrier solution to UK's unsafe cladding dilemma
Light Science Technologies Holdings PLC (AIM:LST) CEO Simon Deacon talked with Proactive's Stephen Gunnion about the significant opportunity surrounding the company’s Injecta Fire Barrier solution, particularly in light of ongoing fire safety issues in the UK’s residential building sector. Deacon highlighted that the UK still has more than 33,000 buildings between 11m and 18m in height, and over 11,000 high-risk buildings above 18m, that require urgent fire protection measures. He referenced a government estimate suggesting a potential £22 billion cost to address the cladding crisis, which has persisted since the Grenfell tragedy. The Injecta Fire Barrier, acquired in late 2023, offers what Deacon described as a "unique solution"—one that avoids facade removal by injecting fire-resistant material directly into cavities, providing over two hours of fire resistance. He said, "We're three times less in cost and much quicker to install than traditional methods." He noted the division secured £2.7 million in orders during 2024, performing strongly and receiving positive feedback for its efficiency and clean delivery. With an average order value over £500,000 and significant market scope, Deacon framed the opportunity as a scalable revenue driver for the group. The company is targeting £50 million in revenue over the next five years, with Injecta Fire Barrier expected to be a key growth driver. 👉 For more updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and enable notifications for future content. #FireSafety #BuildingSafety #InjectaFireBarrier #LightScienceTechnologies #GrenfellLegacy #PropertyInvestment #ConstructionInnovation #FireProtection #CladdingCrisis #UKHousingSafety #ProactiveInvestors #SimonDeacon #BuildingRegulations #RealEstateSafety #PassiveFireProtection